These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10376511)

  • 21. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Kimmelstiel CD; Maron BJ
    Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
    [No Abstract]   [Full Text] [Related]  

  • 23. Substitution of ethanol with specially designed microspheres in a TASH procedure.
    Latsios G; Gerckens U; Mueller R; Grube E
    EuroIntervention; 2011 Feb; 6(7):889-92. PubMed ID: 21252025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol septal ablation for failed surgical myectomy.
    Juliano N; Wong SC; Naidu SS
    J Invasive Cardiol; 2005 Oct; 17(10):569-71. PubMed ID: 16204755
    [No Abstract]   [Full Text] [Related]  

  • 25. Percutaneous transluminal septal myocardial ablation: a new treatment for hypertrophic obstructive cardiomyopathy.
    Seggewiss H
    Eur Heart J; 2000 May; 21(9):704-7. PubMed ID: 10739723
    [No Abstract]   [Full Text] [Related]  

  • 26. Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar.
    Efthimiadis GK; Mezilis NE; Giannakoulas G; Parcharidis GE
    Eur Heart J; 2007 May; 28(10):1270-1; author reply 1271. PubMed ID: 17463007
    [No Abstract]   [Full Text] [Related]  

  • 27. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Faber L
    Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol septal ablation and the Brockenbrough-Braunwald phenomenon.
    Soon CY; Buergler JM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):1016-24. PubMed ID: 19021274
    [No Abstract]   [Full Text] [Related]  

  • 29. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.
    Cheng TO
    Am J Cardiol; 2004 Oct; 94(7):982. PubMed ID: 15464700
    [No Abstract]   [Full Text] [Related]  

  • 30. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum].
    Veselka J
    Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The potential of magnetic resonance imaging for the surveillance of septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A case report].
    Chassaing S; Garrigoux P; Redheuil A; Blanchard D; Bar O; Maudière A; Mousseaux E
    Arch Mal Coeur Vaiss; 2006 Sep; 99(9):828-31. PubMed ID: 17067103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear magnetic resonance for the assessment of the effects of alcohol septal ablation in hypertrophic cardiomyopathy.
    Kornacewicz-Jach Z; Wojtarowicz A; Goos H; Schulz-Menger J; Goracy J; Płońska E; Przybycień K
    Kardiol Pol; 2004 Nov; 61(11):461-7. PubMed ID: 15883594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
    Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR
    J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
    Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
    Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term electrocardiographic findings in patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
    Haghjoo M
    J Electrocardiol; 2007 Oct; 40(4):357.e1-2. PubMed ID: 17599476
    [No Abstract]   [Full Text] [Related]  

  • 38. Septal alcoholization in hypertrophic cardiomyopathy: about 11 cases.
    Kambiré Y; Millogo GRC; Dauphin C; Lusson JR
    Pan Afr Med J; 2017; 27():196. PubMed ID: 28904721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    van Dockum WG; Beek AM; ten Cate FJ; ten Berg JM; Bondarenko O; Götte MJ; Twisk JW; Hofman MB; Visser CA; van Rossum AC
    Circulation; 2005 May; 111(19):2503-8. PubMed ID: 15867172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The induction of a septal infarct as a therapeutic alternative in hypertrophic obstructive cardiomyopathy: new observations apropos a case].
    de la Torre Hernández JM; Sánchez Mata N; Riesco Riesco F; Ruiz Delgado B; Ochoteco Azcárate A; Zueco Gil J; Colman Dejean T
    Rev Esp Cardiol; 1999 May; 52(5):339-42. PubMed ID: 10368585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.